Rock Springs Capital Management LP Q3 2016 Filing
Filed November 14, 2016
Portfolio Value
$1.6B
Holdings
137
Report Date
Q3 2016
Filing Type
13F-HR
All Holdings (137 positions)
| Stock | Value |
|---|---|
—TESARO INC | $62.8M |
—AETNA INC NEW | $50.8M |
—RADIUS HEALTH INC | $48.2M |
ACHCACADIA HEALTHCARE COMPANY IN | $45.8M |
—GW PHARMACEUTICALS PLC | $43.1M |
—ALLERGAN PLC | $42.8M |
—SPARK THERAPEUTICS INC | $37.5M |
MRKMERCK & CO INC | $36.7M |
PFEPFIZER INC | $35.8M |
—ADVANCED ACCELERATOR APPLIC | $35.4M |
ALXNALEXION PHARMACEUTICALS INC | $32.7M |
ISRGINTUITIVE SURGICAL INC | $32.6M |
HCAHCA HOLDINGS INC | $32.5M |
CICIGNA CORPORATION | $29.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $29.8M |
WCGEURWELLCARE HEALTH PLANS INC | $27.5M |
GILDGILEAD SCIENCES INC | $27.2M |
CELGCELGENE CORP | $26.6M |
ACRSACLARIS THERAPEUTICS INC | $26.0M |
—MEDICINES CO | $25.7M |
—SHIRE PLC | $25.7M |
ARDXARDELYX INC | $25.6M |
LLYLILLY ELI & CO | $22.2M |
TBPHTHERAVANCE BIOPHARMA INC | $21.7M |
CLSDUSDCLEARSIDE BIOMEDICAL INC | $21.3M |
NBIXNEUROCRINE BIOSCIENCES INC | $20.8M |
PENPENUMBRA INC | $20.3M |
PRTAPROTHENA CORP PLC | $18.5M |
BIIBBIOGEN INC | $18.2M |
PCRXPACIRA PHARMACEUTICALS INC | $17.2M |
AMRNAMARIN CORP PLC | $15.8M |
AMGNAMGEN INC | $15.7M |
—WRIGHT MED GROUP N V | $15.0M |
INCYINCYTE CORP | $14.8M |
PRAHPRA HEALTH SCIENCES INC | $14.3M |
MCKMCKESSON CORP | $13.7M |
GLPGGALAPAGOS NV | $13.6M |
BMYBRISTOL MYERS SQUIBB CO | $13.5M |
JAZZJAZZ PHARMACEUTICALS PLC | $13.0M |
WBAWALGREENS BOOTS ALLIANCE INC | $13.0M |
DHRDANAHER CORP DEL | $12.5M |
CHRSCOHERUS BIOSCIENCES INC | $12.5M |
EWEDWARDS LIFESCIENCES CORP | $12.4M |
—THERAPEUTICSMD INC | $12.3M |
—DERMIRA INC | $12.0M |
—PATHEON N V | $11.9M |
—RETROPHIN INC | $11.7M |
BMRNBIOMARIN PHARMACEUTICAL INC | $11.6M |
—HEALTHSOUTH CORP | $10.8M |
—ACHILLION PHARMACEUTICALS IN | $10.7M |
SRPTSAREPTA THERAPEUTICS INC | $10.6M |
RAREULTRAGENYX PHARMACEUTICAL IN | $10.4M |
HOLXHOLOGIC INC | $9.8M |
—FIVE PRIME THERAPEUTICS INC | $8.7M |
—AUDENTES THERAPEUTICS INC | $8.6M |
ALKSALKERMES PLC | $8.6M |
EXASEXACT SCIENCES CORP | $8.1M |
VRTXVERTEX PHARMACEUTICALS INC | $7.8M |
NVTA1EURINVITAE CORP | $7.8M |
WTWWILLIS TOWERS WATSON PUB LTD | $7.8M |
HRCHILL ROM HLDGS INC | $7.4M |
CRVSCORVUS PHARMACEUTICALS INC | $7.4M |
IM8NINSMED INC | $7.3M |
—PROTEOSTASIS THERAPEUTICS IN | $7.0M |
ONCBEIGENE LTD | $6.9M |
REGNREGENERON PHARMACEUTICALS | $6.8M |
—OPHTHOTECH CORP | $6.8M |
MGNXMACROGENICS INC | $6.7M |
—EGALET CORP | $6.7M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $6.6M |
LGNDLIGAND PHARMACEUTICALS INC | $6.6M |
—PARATEK PHARMACEUTICALS INC | $6.5M |
—ENVISION HEALTHCARE HLDGS IN | $6.5M |
—NOVADAQ TECHNOLOGIES INC | $6.4M |
MRUSMERUS N V | $6.4M |
—EPIZYME INC | $6.3M |
ASNDASCENDIS PHARMA A S | $6.0M |
—ALDER BIOPHARMACEUTICALS INC | $6.0M |
—JUNO THERAPEUTICS INC | $5.9M |
—RTI SURGICAL INC | $5.8M |
—ATHENAHEALTH INC | $5.8M |
—AVEXIS INC | $5.8M |
—ENDOCHOICE HLDGS INC | $5.8M |
—INTERSECT ENT INC | $5.5M |
CGENCOMPUGEN LTD | $5.2M |
—ADURO BIOTECH INC | $5.2M |
AM6AMICUS THERAPEUTICS INC | $5.1M |
FGENEURFIBROGEN INC | $4.8M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $4.8M |
PBYIPUMA BIOTECHNOLOGY INC | $4.7M |
—TANDEM DIABETES CARE INC | $4.6M |
CLVSEURCLOVIS ONCOLOGY INC | $4.5M |
—CHINA CORD BLOOD CORP | $4.5M |
—KITE PHARMA INC | $4.4M |
—AIMMUNE THERAPEUTICS INC | $4.4M |
—BIOSCRIP INC | $4.3M |
—ALLERGAN PLC | $4.1M |
MEDPMEDPACE HLDGS INC | $4.0M |
—NIVALIS THERAPEUTICS INC | $4.0M |
—MEDICINES CO | $3.9M |
Page 1 of 2Next